Goa Plant I

Indoco Remedies Goa Plant I manufactures Solid Dosages, Creams, Ointments and Liquid Dosages and is located in a non-pollutant area, with a vertical flow system, monolithic flooring, fully air-conditioned RM and FG stores. It has a separate Pilot Plant. The plant has capability to manufacture Aqueous, Non-aqueous and Photosensitive products. It has HVAC system that maintains Relative Humidity to 55% +/- 5%. The facility has now been expanded to meet the growing demands by our customers from the regulated markets.

The facility is approved by UK-MHRA (for Solid Dosages and Creams & Capsules), TGA-Australia (for Solid Dosages, Liquid Orals and Creams & Ointments) and by Darmstadt Germany (for Solid Dosages). The Plant also holds the WHO-GMP approval.

Dosages manufactured and their annual capacities:

• Solid Orals (Tablets Coated / Uncoated) : 2 Billion Tablets

• Liquid Orals : 6 Million Bottles

• Creams & Ointments : 10 Million Tubes

• Capsules (Hard Gelatin) : 60 Million Capsules

Goa Plant II

This is a state-of-the-art sterile facility for Ophthalmics and Injectables approved by USFDA. This facility has also been approved by Ministry of Health - Tanzania, UKMHRA, ANVISA, ENVIMA & NAFDAC-NIGERIA.

The Plant has been designed with a sophisticated internal environment monitoring system using PC based system to monitor and control parameters like temperature, humidity, pressure difference, particulate count and safety aspects. The Design of the plant is modular.

Dosages manufactured and their annual capacities:

• Ampoules : 15 Million

• Vials/ Bottles : 20 Million

Goa Plant III

Indoco Remedies Goa Plant III has a capability to manufacture Aqueous, Non-Aqueous and photo sensitive products. The Plant is located in a non-pollutant industrial area, with a vertical flow system along with monolithic flooring. It has HVAC system that maintains relative humidity to 55% +/-5% and temperature between 20⁰C to 25⁰ C along with pressure differential and SCADA system to control and monitor Rh & temperature. The equipment designs at the plant can cater to latest manufacturing technologies like spray granulations. The plant also houses a pilot production facility.

The facility is approved by USFDA, TGA-Australia and Bavarian Health Authority-Germany and has the capacity to manufacture 1.8 billion tablets annually.

Baddi Plant I

Indoco's manufacturing facility in BADDI, Himachal Pradesh manufactures tablets, creams, ointments, liquid orals and toothpaste. The facility supports the Company’s growing formulations requirements for the domestic as well as international business.

The manufacturing facility has been designed for logical flow of men and materials. The plant has been provided with all necessary arrangements to eliminate the risk of errors, avoid cross border contamination and mix up.

Dosages manufactured and their annual capacities :

• Solid Orals (Tablets) : 0.96 Billion

• Liquid Orals : 2400 KL

• External Preparations (Creams & Ointments) : 225 Tons

• Oral Hygiene preparation (Toothpaste) : 1500 Tons

This facility has been approved by UK-MHRA (for Solid Dosages), World Health Organization, Ministry of Health - Nepal and has also successfully faced audit from Ministry of Health, Slovenia.

Baddi Plant III

This Oral Solid Dosage (OSD) manufacturing facility located at Baddi has been acquired from Micro Labs Ltd., Bangalore. The facility is spread over an area of 18,000 sqm, out of which 11,000 is the built-up area. The facility is designed for production of a variety of tablets and hard gelatin capsules.

The acquisition is fuelled by the anticipated high growth in the Company’s international business in the coming future and will cater mainly to the Regulated markets. This facility has been approved by UKMHRA & WHO-GMP.

Dosages manufactured and their annual capacities :

• Solid Orals (Tablets/Capsules) : 3 billion

Waluj Plant

Indoco's Waluj manufacturing facility is located in Aurangabad is spread over and an area of 8100 sq.mts. The total built up area is approximately 4500 sq. mts. This facility has been designed for logical flow of men & material and has been provided with all necessary arrangements to eliminate the risk of errors, avoid cross contamination and mix up. The site is surrounded by non-polluting industries which do not generate any smoke, soot or dust.

Dosages manufactured and their annual capacities :

• Solid Orals (Tablets) : 250 Million

• Liquid Orals : 500 KL

• External Preparations : 400 KL

This facility has been inspected by World Health Organization, National Drug Authority - Uganda, Drug Regulatory Unit – Botswana, PPB Kenya, TMDA Tanzania, MEDS Kenya, TPML France (FWA), ZAMRA – Zambia